GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Operating Margin %

Cardia Bioplastics (ASX:CNN) Operating Margin % : -48.38% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Cardia Bioplastics's Operating Income for the six months ended in Dec. 2023 was A$-3.00 Mil. Cardia Bioplastics's Revenue for the six months ended in Dec. 2023 was A$6.19 Mil. Therefore, Cardia Bioplastics's Operating Margin % for the quarter that ended in Dec. 2023 was -48.38%.

The historical rank and industry rank for Cardia Bioplastics's Operating Margin % or its related term are showing as below:

ASX:CNN' s Operating Margin % Range Over the Past 10 Years
Min: -56.18   Med: -15.24   Max: 1.48
Current: -37.49


ASX:CNN's Operating Margin % is ranked worse than
96.36% of 385 companies
in the Packaging & Containers industry
Industry Median: 6 vs ASX:CNN: -37.49

Cardia Bioplastics's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Cardia Bioplastics's Operating Income for the six months ended in Dec. 2023 was A$-3.00 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was A$-6.47 Mil.


Cardia Bioplastics Operating Margin % Historical Data

The historical data trend for Cardia Bioplastics's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Operating Margin % Chart

Cardia Bioplastics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18.54 -6.69 1.48 -9.17 -26.41

Cardia Bioplastics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.94 -13.28 -21.70 -31.40 -48.38

Competitive Comparison of Cardia Bioplastics's Operating Margin %

For the Packaging & Containers subindustry, Cardia Bioplastics's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardia Bioplastics's Operating Margin % Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's Operating Margin % falls into.



Cardia Bioplastics Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Cardia Bioplastics's Operating Margin % for the fiscal year that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=-6.03 / 22.836
=-26.41 %

Cardia Bioplastics's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-2.996 / 6.193
=-48.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardia Bioplastics  (ASX:CNN) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Cardia Bioplastics Operating Margin % Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardia Bioplastics (ASX:CNN) Business Description

Traded in Other Exchanges
Address
247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149
SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines